These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 27656862)

  • 21. [Large part of Swedish men PSA tested for early prostatic cancer. Few aware of the disadvantages of the test].
    Bratt O; Grenabo L
    Lakartidningen; 2010 Feb 17-23; 107(7):432-5. PubMed ID: 20384075
    [No Abstract]   [Full Text] [Related]  

  • 22. Impact of Prostate-specific Antigen (PSA) Screening Trials and Revised PSA Screening Guidelines on Rates of Prostate Biopsy and Postbiopsy Complications.
    Gershman B; Van Houten HK; Herrin J; Moreira DM; Kim SP; Shah ND; Karnes RJ
    Eur Urol; 2017 Jan; 71(1):55-65. PubMed ID: 26995328
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prostate-specific antigen-based screening: controversy and guidelines.
    Kim EH; Andriole GL
    BMC Med; 2015 Mar; 13():61. PubMed ID: 25857320
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Editorial: Prostate cancer screening: perhaps a little patience is the answer.
    Jarrett TW
    Can J Urol; 2012 Oct; 19(5):6409. PubMed ID: 23040616
    [No Abstract]   [Full Text] [Related]  

  • 25. An Approach Using PSA Levels of 1.5 ng/mL as the Cutoff for Prostate Cancer Screening in Primary Care.
    Crawford ED; Rosenberg MT; Partin AW; Cooperberg MR; Maccini M; Loeb S; Pettaway CA; Shore ND; Arangua P; Hoenemeyer J; Leveridge M; Leapman M; Pinto P; Thompson IM; Carroll P; Eastham J; Gomella L; Klein EA
    Urology; 2016 Oct; 96():116-120. PubMed ID: 27450937
    [No Abstract]   [Full Text] [Related]  

  • 26. Current guidelines for prostate cancer screening: A systematic review and minimal core proposal.
    Araujo FAGDR; Oliveira U
    Rev Assoc Med Bras (1992); 2018 Mar; 64(3):290-296. PubMed ID: 29641784
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comment on the US Preventive Services Task Force's draft recommendation on screening for prostate cancer.
    Kwiatkowski M; Klotz L; Hugosson J; Recker F
    Eur Urol; 2012 Apr; 61(4):851-4. PubMed ID: 22285762
    [No Abstract]   [Full Text] [Related]  

  • 28. Prostate specific antigen and screening for early prostate cancer.
    Davidson P
    N Z Med J; 2001 Apr; 114(1129):150. PubMed ID: 11400919
    [No Abstract]   [Full Text] [Related]  

  • 29. Prostate-specific antigen screening, why have the guidelines changed?
    Sountoulides P; Moutzouris G
    Expert Rev Anticancer Ther; 2014 Nov; 14(11):1277-81. PubMed ID: 25306859
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Will Changes to Prostate Cancer Screening Guidelines Preserve Benefits and Reduce Harm?
    Loeb S
    Eur Urol; 2017 Jan; 71(1):66-67. PubMed ID: 27090973
    [No Abstract]   [Full Text] [Related]  

  • 31. Prostate cancer screening in men 75 years old or older: an assessment of self-reported health status and life expectancy.
    Hoffman KE; Nguyen PL; Ng AK; D'Amico AV
    J Urol; 2010 May; 183(5):1798-802. PubMed ID: 20299039
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prostate-specific antigen, prostate cancer screening, and the pathologist: what should be our role?
    Jackson BR
    Arch Pathol Lab Med; 2013 Mar; 137(3):308-9. PubMed ID: 22799565
    [No Abstract]   [Full Text] [Related]  

  • 33. Prostate-specific antigen screening for prostate cancer in older men in the United States of America.
    Black A; Berg CD
    Gerontology; 2012; 58(4):331-6. PubMed ID: 22343605
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The current state of prostate-specific antigen testing.
    Lewis R; Hornberger B
    JAAPA; 2016 Sep; 29(9):51-3. PubMed ID: 27575906
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prostate specific antigen for detecting early prostate cancer.
    Ilic D; Green S
    BMJ; 2009 Sep; 339():b3572. PubMed ID: 19778970
    [No Abstract]   [Full Text] [Related]  

  • 36. Further evidence that prostate-specific antigen screening reduces prostate cancer mortality.
    Stampfer MJ; Jahn JL; Gann PH
    J Natl Cancer Inst; 2014 Mar; 106(3):dju026. PubMed ID: 24610908
    [No Abstract]   [Full Text] [Related]  

  • 37. Clinical practice. Prostate-specific-antigen testing for early diagnosis of prostate cancer.
    Barry MJ
    N Engl J Med; 2001 May; 344(18):1373-7. PubMed ID: 11333995
    [No Abstract]   [Full Text] [Related]  

  • 38. Evolution and immediate future of US screening guidelines.
    Greene KL; Punnen S; Carroll PR
    Urol Clin North Am; 2014 May; 41(2):229-35. PubMed ID: 24725485
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Decision making and prostate cancer screening.
    Knight SJ
    Urol Clin North Am; 2014 May; 41(2):257-66. PubMed ID: 24725488
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Screening for Prostate Cancer Starting at Age 50-54 Years. A Population-based Cohort Study.
    Carlsson S; Assel M; Ulmert D; Gerdtsson A; Hugosson J; Vickers A; Lilja H
    Eur Urol; 2017 Jan; 71(1):46-52. PubMed ID: 27084245
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.